Randeep Guleria

Title: Randeep Guleria: Innovator in Pharmacogenetics

Introduction

Randeep Guleria is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmacogenetics, particularly in understanding the bronchodilatory response to beta agonists. His work has implications for personalized medicine and improving patient outcomes.

Latest Patents

Randeep Guleria holds 2 patents that focus on methods for predicting an individual's bronchodilatory response to beta agonists. His latest patents include:

1. **Primers for amplifying and detecting the beta 2 adrenergic receptor gene** - This invention relates to a method for predicting an individual's bronchodilatory response to a β agonist. It particularly focuses on the detection of specific allelic variants of the β2AR gene and their use as pharmacogenetic markers towards response to β agonists.

2. **Method of detecting and predicting bronchodilatory response to beta agonist** - Similar to his first patent, this invention also relates to predicting an individual's bronchodilatory response to a β agonist, emphasizing the detection of specific allelic variants of the β2AR gene.

Career Highlights

Throughout his career, Randeep Guleria has worked with esteemed organizations such as the Council of Scientific and Industrial Research and Piramal Life Sciences Limited. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in the field.

Collaborations

Randeep has collaborated with notable coworkers, including Ritushree Kukreti and Pallav Bhatnagar. Their joint efforts have furthered research in pharmacogenetics and related fields.

Conclusion

Randeep Guleria's work in pharmacogenetics and his innovative patents highlight his commitment to advancing medical science. His contributions are paving the way for more personalized approaches to treatment, ultimately benefiting patients worldwide.